Hemopatch Application for Ventricular Wall Laceration in Redo Cardiac Surgical Procedures

Stany Sandrio; Ariawan Purbojo; Robert A Cesnjevar; André Rüffer

doi:10.1016/j.athoracsur.2015.04.082

Hemopatch Application for Ventricular Wall Laceration in Redo Cardiac Surgical Procedures

Ann Thorac Surg. 2016 Feb;101(2):752-3. doi: 10.1016/j.athoracsur.2015.04.082.

Authors

Stany Sandrio¹, Ariawan Purbojo², Robert A Cesnjevar², André Rüffer²

Affiliations

¹ Department of Pediatric Cardiac Surgery, Friedrich-Alexander-University Erlangen-Nuremberg, Erlangen, Germany. Electronic address: [email protected].
² Department of Pediatric Cardiac Surgery, Friedrich-Alexander-University Erlangen-Nuremberg, Erlangen, Germany.

PMID: 26777931
DOI: 10.1016/j.athoracsur.2015.04.082

Abstract

As survival among patients with complex congenital heart disease continues to improve, long-term survivors frequently require redo surgical procedures, with potentially escalating technical difficulty and bleeding risk. This report describes our experience with a new hemostatic pad, Hemopatch (Baxter Deutschland GmbH, Unterschleissheim, Germany) in redo cardiac surgery.

Publication types

Case Reports

MeSH terms

Adolescent
Cardiac Surgical Procedures*
Female
Heart Injuries / complications*
Heart Ventricles / injuries*
Hemorrhage / drug therapy*
Hemorrhage / etiology*
Hemostatics / administration & dosage*
Humans
Lacerations / complications*
Lacerations / etiology
Reoperation / adverse effects

Substances

Hemostatics